NCT00616538View on ClinicalTrials.gov

Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

April 30, 2007

Conditions
Atopic Dermatitis
Interventions
DEVICE

Epiceram(r)

Topical barrier repair emulsion cream

DRUG

Fluticasone Propionate 0.05%

Topical mid-strength steroid

Sponsors
All Listed Sponsors
lead

Ceragenix Pharmaceuticals

INDUSTRY